Slingsby Brian Taylor sold 104,320 shares of Mineralys Therapeutics, Inc. at $28.81 for −$3.01M on Sep 22, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Director
DIR
Filed Sep 24, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$3,005,302.72Shares × reported price
Shares traded
104,320Common Stock
Price per share
$28.81Reported price. Read footnotes for ranges.
% of reported position traded
1.32%This security and ownership context
Holdings after
7,805,718Indirect · See footnote
Trade date
Sep 22, 2026Sell
Filed
Sep 24, 2026, 9:49 PM ET3-day reporting delay
Accession
0001963901-26-000003Code S · Transaction 229513
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 7,910,038 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

MLYS price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
MLYS · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −0.8%1w ago +2%1d ago +9.5%
Returns since7d −8.6%30d −21%90d180d1y

Footnotes in full

F1: Represents shares of common stock sold by Catalys Pacific Fund, LP. See footnote (3). F2: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $28.700 to $28.905. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: Represents shares of common stock held of record by Catalys Pacific Fund, LP. Catalys Pacific Fund GP, LP is the general partner of Catalys Pacific Fund, LP. Catalys Pacific, LLC is the general partner of Catalys Pacific Fund GP, LP, and Mr. Slingsby is the managing partner of Catalys Pacific, LLC. Accordingly, Mr. Slingsby may be deemed to share voting and investment power over the shares held of record by Catalys Pacific Fund, LP. Mr. Slingsby disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.